Sequencing Consumables Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User

PUBLISHED: April 20, 2026

PAGES: 350 Pages

DELIVERY TIME: 3-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

The global Sequencing Consumables Market is projected to grow from $9.4 billion in 2025 to $65.3 billion by 2035, at a compound annual growth rate (CAGR) of 17.8%. Demand is high, with millions of sequencing runs conducted annually using consumables supplied by companies like Illumina Inc.. These include reagents, kits, and flow cells essential for next-generation sequencing. Pricing typically ranges from USD 500 to USD 1,500 per run depending on throughput and application. Consumables represent a recurring revenue stream, as each sequencing process requires new materials. Cost reductions over time have improved accessibility, while increasing adoption in diagnostics, research, and personalized medicine continues to drive both volume and revenue growth.

The Application segment in the sequencing consumables market is primarily dominated by clinical diagnostics, driven by the increasing use of sequencing technologies to identify genetic mutations and support precision medicine. The rising prevalence of cancer and genetic disorders has significantly increased the demand for accurate and early diagnosis, where sequencing plays a critical role. Applications such as companion diagnostics and non-invasive prenatal testing (NIPT) are expanding rapidly, enabling targeted therapies and early-stage disease detection. Continuous advancements in next-generation sequencing (NGS) technologies are further enhancing efficiency, accuracy, and accessibility, thereby strengthening growth in this segment.

Market Segmentation
Type	Reagents, Kits, Enzymes, Buffers, Beads, Plates, Tubes, Others
Product	DNA Sequencing Consumables, RNA Sequencing Consumables, Protein Sequencing Consumables, Others
Services	Sequencing Services, Bioinformatics Services, Others
Technology	Next-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Others
Component	Consumables, Instruments, Software, Others
Application	Clinical Diagnostics, Drug Discovery, Agricultural and Animal Research, Forensic Science, Environmental Testing, Others
Material Type	Plastic, Glass, Silicon, Others
Process	Library Preparation, Sequencing, Data Analysis, Others
End User	Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Contract Research Organizations, Others

The End User segment is led by academic and research institutions, which extensively use sequencing consumables for genomic research, biomarker discovery, and large-scale population studies. These institutions are supported by increasing government funding and global initiatives focused on advancing genomics research. Pharmaceutical and biotechnology companies also represent a major share, utilizing sequencing for drug discovery, clinical trials, and development of personalized therapies. Growing collaborations between academia and industry players are accelerating innovation and expanding applications of sequencing technologies, reinforcing the importance of consumables in driving advancements in healthcare and life sciences.

Geographical Overview

North America holds the largest market share in the Sequencing Consumables Market due to its strong genomics research ecosystem, high healthcare spending, and early adoption of next-generation sequencing (NGS) technologies. The United States dominates the region with extensive use of sequencing in oncology, rare disease diagnostics, infectious disease tracking, and precision medicine programs. Leading biotechnology firms, academic research institutions, and large-scale genomic initiatives significantly drive consumables demand such as reagents, library preparation kits, and flow cells. Strong funding from government agencies and private investors further accelerates genomic research activities, making North America the primary revenue-generating region in the global sequencing consumables landscape.

Asia Pacific is expected to register the highest CAGR in the Sequencing Consumables Market due to rapid expansion of genomics research, increasing healthcare investments, and growing adoption of precision medicine. Countries such as China, India, Japan, and South Korea are investing heavily in large-scale genomic sequencing programs and national bio-banking initiatives. Rising prevalence of genetic disorders and infectious diseases is also driving demand for advanced sequencing technologies. Expanding biotechnology industries, increasing academic research collaborations, and declining sequencing costs further support market growth. Government-backed genomics projects and increasing clinical integration of NGS technologies position Asia Pacific as the fastest-growing regional market globally.

Key Trends and Drivers

Rapid growth in genomic research and precision medicine adoption

A key driver of the Sequencing Consumables Market is the rapid expansion of genomic research and the increasing adoption of precision medicine approaches. Next-generation sequencing technologies are widely used for identifying genetic variations, diagnosing rare diseases, and developing targeted therapies. The growing demand for personalized treatment strategies in oncology and chronic diseases is significantly increasing the consumption of sequencing consumables such as reagents, kits, and sample preparation materials. Additionally, large-scale genome mapping projects and rising investment in biotechnology research are accelerating market growth. Continuous technological advancements in sequencing platforms further enhance accuracy, throughput, and overall demand for consumables globally.

Expansion of clinical genomics and population-scale sequencing programs

A major opportunity in the Sequencing Consumables Market lies in the expansion of clinical genomics and large-scale population sequencing programs. Governments and healthcare organizations are increasingly investing in national genome initiatives to improve disease prediction, prevention, and personalized treatment. Integration of sequencing into routine clinical diagnostics is expanding applications beyond research into mainstream healthcare. Additionally, declining costs of sequencing are enabling broader adoption in emerging economies. Growth in infectious disease surveillance, cancer genomics, and pharmacogenomics further strengthens demand. Increasing partnerships between biotech companies, hospitals, and research institutes are expected to significantly expand the market for sequencing consumables globally.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS34512

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Process
2.7 Key Market Highlights by Component
2.8 Key Market Highlights by Services
2.9 Key Market Highlights by Material Type

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Reagents
- 4.1.2 Kits
- 4.1.3 Enzymes
- 4.1.4 Buffers
- 4.1.5 Beads
- 4.1.6 Plates
- 4.1.7 Tubes
- 4.1.8 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 DNA Sequencing Consumables
- 4.2.2 RNA Sequencing Consumables
- 4.2.3 Protein Sequencing Consumables
- 4.2.4 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Next-Generation Sequencing (NGS)
- 4.3.2 Sanger Sequencing
- 4.3.3 Single-Molecule Real-Time (SMRT) Sequencing
- 4.3.4 Nanopore Sequencing
- 4.3.5 Others
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Clinical Diagnostics
- 4.4.2 Drug Discovery
- 4.4.3 Agricultural and Animal Research
- 4.4.4 Forensic Science
- 4.4.5 Environmental Testing
- 4.4.6 Others
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Academic and Research Institutes
- 4.5.2 Pharmaceutical and Biotechnology Companies
- 4.5.3 Hospitals and Clinics
- 4.5.4 Contract Research Organizations
- 4.5.5 Others
4.6 Market Size & Forecast by Process (2020-2035)
- 4.6.1 Library Preparation
- 4.6.2 Sequencing
- 4.6.3 Data Analysis
- 4.6.4 Others
4.7 Market Size & Forecast by Component (2020-2035)
- 4.7.1 Consumables
- 4.7.2 Instruments
- 4.7.3 Software
- 4.7.4 Others
4.8 Market Size & Forecast by Services (2020-2035)
- 4.8.1 Sequencing Services
- 4.8.2 Bioinformatics Services
- 4.8.3 Others
4.9 Market Size & Forecast by Material Type (2020-2035)
- 4.9.1 Plastic
- 4.9.2 Glass
- 4.9.3 Silicon
- 4.9.4 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 End User
  - 5.2.1.6 Process
  - 5.2.1.7 Component
  - 5.2.1.8 Services
  - 5.2.1.9 Material Type
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 End User
  - 5.2.2.6 Process
  - 5.2.2.7 Component
  - 5.2.2.8 Services
  - 5.2.2.9 Material Type
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 End User
  - 5.2.3.6 Process
  - 5.2.3.7 Component
  - 5.2.3.8 Services
  - 5.2.3.9 Material Type
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 End User
  - 5.3.1.6 Process
  - 5.3.1.7 Component
  - 5.3.1.8 Services
  - 5.3.1.9 Material Type
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 End User
  - 5.3.2.6 Process
  - 5.3.2.7 Component
  - 5.3.2.8 Services
  - 5.3.2.9 Material Type
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 End User
  - 5.3.3.6 Process
  - 5.3.3.7 Component
  - 5.3.3.8 Services
  - 5.3.3.9 Material Type
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 End User
  - 5.4.1.6 Process
  - 5.4.1.7 Component
  - 5.4.1.8 Services
  - 5.4.1.9 Material Type
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 End User
  - 5.4.2.6 Process
  - 5.4.2.7 Component
  - 5.4.2.8 Services
  - 5.4.2.9 Material Type
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 End User
  - 5.4.3.6 Process
  - 5.4.3.7 Component
  - 5.4.3.8 Services
  - 5.4.3.9 Material Type
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 End User
  - 5.4.4.6 Process
  - 5.4.4.7 Component
  - 5.4.4.8 Services
  - 5.4.4.9 Material Type
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 End User
  - 5.4.5.6 Process
  - 5.4.5.7 Component
  - 5.4.5.8 Services
  - 5.4.5.9 Material Type
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 End User
  - 5.4.6.6 Process
  - 5.4.6.7 Component
  - 5.4.6.8 Services
  - 5.4.6.9 Material Type
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 End User
  - 5.4.7.6 Process
  - 5.4.7.7 Component
  - 5.4.7.8 Services
  - 5.4.7.9 Material Type
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 End User
  - 5.5.1.6 Process
  - 5.5.1.7 Component
  - 5.5.1.8 Services
  - 5.5.1.9 Material Type
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 End User
  - 5.5.2.6 Process
  - 5.5.2.7 Component
  - 5.5.2.8 Services
  - 5.5.2.9 Material Type
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 End User
  - 5.5.3.6 Process
  - 5.5.3.7 Component
  - 5.5.3.8 Services
  - 5.5.3.9 Material Type
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 End User
  - 5.5.4.6 Process
  - 5.5.4.7 Component
  - 5.5.4.8 Services
  - 5.5.4.9 Material Type
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 End User
  - 5.5.5.6 Process
  - 5.5.5.7 Component
  - 5.5.5.8 Services
  - 5.5.5.9 Material Type
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 End User
  - 5.5.6.6 Process
  - 5.5.6.7 Component
  - 5.5.6.8 Services
  - 5.5.6.9 Material Type
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 End User
  - 5.6.1.6 Process
  - 5.6.1.7 Component
  - 5.6.1.8 Services
  - 5.6.1.9 Material Type
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 End User
  - 5.6.2.6 Process
  - 5.6.2.7 Component
  - 5.6.2.8 Services
  - 5.6.2.9 Material Type
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 End User
  - 5.6.3.6 Process
  - 5.6.3.7 Component
  - 5.6.3.8 Services
  - 5.6.3.9 Material Type
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 End User
  - 5.6.4.6 Process
  - 5.6.4.7 Component
  - 5.6.4.8 Services
  - 5.6.4.9 Material Type
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 End User
  - 5.6.5.6 Process
  - 5.6.5.7 Component
  - 5.6.5.8 Services
  - 5.6.5.9 Material Type

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Illumina
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Thermo Fisher Scientific
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Agilent Technologies
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Qiagen
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Bio-Rad Laboratories
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Roche Diagnostics
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 PerkinElmer
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Pacific Biosciences
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Oxford Nanopore Technologies
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Becton Dickinson
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Takara Bio
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Fluidigm
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 10x Genomics
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Promega Corporation
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 New England Biolabs
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 LGC Biosearch Technologies
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Integrated DNA Technologies
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Zymo Research
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Eurofins Scientific
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 BGI Genomics
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis